Kathleen Simpson, M.D.  simpson_k@kids.wustl.edu

Assistant Professor of Pediatrics, Cardiology

phone: (314) 454-6095


  • BA, University of Missouri - Kansas City2006
  • MD, University of Missouri - Kansas City School of Medicine2006


  • Residency, Pediatrics, University of Missouri-Kansas City School of Medicine-Children's Mercy Hospitals and Clinics2006 - 2009
  • Fellowship, Pediatric Cardiology, Washington University in Saint Louis - St. Louis Children's Hospital2009 - 2012
  • Fellowship, Pediatric Heart Failure and Transplant, Washington University in Saint Louis - St. Louis Children's Hospital2012 - 2013

Licensure and Board Certification

  • MO, Missouri State Medical License 2006
  • General Pediatrics Board Certification 2009
  • Pediatric Cardiology Board Certification 2012


  • Gold Humanism Honor Society Award2006 - 2006

Recent Publications view all (15)

Publication Co-Authors

  1. Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. J Card Fail. 2016;22(7):520-8. PMID:26941007 
  2. Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant. 2016. doi:10.1016/j.healun.2016.02.005  PMID:27068035 
  3. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatr Cardiol. 2016;37(2):399-404. PMCID:PMC4775434  PMID:26499513 
  4. Early Biventricular Assist Device Use in Children: A Single-Center Review of 31 Patients. ASAIO J. 2015;61(6):688-94. PMID:26186261 
  5. Continuous Flow Device Support in Children Using the HeartWare HVAD: 1,000 Days of Lessons Learned From a Single Center Experience. ASAIO J. 2015;61(5):569-73. PMID:25967955 
  6. Pediatric Quality of Life while Supported with a Ventricular Assist Device. Congenit Heart Dis. 2015;10(4):E189-96. doi:10.1111/chd.12260  PMID:25864509 
  7. Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circ Heart Fail. 2015;8(1):64-70. doi:10.1161/CIRCHEARTFAILURE.114.001528  PMID:25472966 
  8. Children with myocarditis and new onset dilated cardiomyopathy have evidence of autoimmunity and viremia at presentation. Progress in Pediatric Cardiology. 2014;37(1):39-40. 
  9. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr Cardiol. 2014;35(3):411-8. doi:10.1007/s00246-013-0794-1  PMCID:PMC3944049  PMID:24061276 
  10. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170-7. doi:10.1016/j.healun.2013.10.033  PMCID:PMC3985609  PMID:24365764 
  11. Fontan-Associated Liver Disease: Reversible with Cardiac Transplantation, or "Past the Point of No Return"? ISHLT Links. 2013;5(5). 
  12. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012;31(5):545-7. doi:10.1016/j.healun.2012.02.003  PMID:22381208 
  13. Successful subxyphoid hybrid approach for placement of a Melody percutaneous pulmonary valve. Catheter Cardiovasc Interv. 2011;78(1):108-11. doi:10.1002/ccd.22930  PMID:21234917 
  14. Atrial tachyarrhythmias in neonatal enterovirus myocarditis. Pediatr Cardiol. 2009;30(6):827-30. doi:10.1007/s00246-009-9398-1  PMID:19294461 
  15. Fontan patient survival after pediatric heart transplantation has improved in the current era The Annals of Thoracic Surgery. 
Wash U School of Medicine
Children's Hospital St. Louis
Children's Discovery Institute
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130